ATE69466T1 - Superoxyddismutase. - Google Patents
Superoxyddismutase.Info
- Publication number
- ATE69466T1 ATE69466T1 AT86905243T AT86905243T ATE69466T1 AT E69466 T1 ATE69466 T1 AT E69466T1 AT 86905243 T AT86905243 T AT 86905243T AT 86905243 T AT86905243 T AT 86905243T AT E69466 T1 ATE69466 T1 AT E69466T1
- Authority
- AT
- Austria
- Prior art keywords
- sod
- superoxide dismutase
- recovering
- growing
- cell
- Prior art date
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 title abstract 3
- 108010012715 Superoxide dismutase Proteins 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK402785A DK402785D0 (da) | 1985-09-03 | 1985-09-03 | Fremgangsmaade til fremstilling af et enzym |
| EP86905243A EP0236385B1 (de) | 1985-09-03 | 1986-09-02 | Superoxyddismutase |
| PCT/DK1986/000098 WO1987001387A1 (en) | 1985-09-03 | 1986-09-02 | A superoxide dismutase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE69466T1 true ATE69466T1 (de) | 1991-11-15 |
Family
ID=8129425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86905243T ATE69466T1 (de) | 1985-09-03 | 1986-09-02 | Superoxyddismutase. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5130245A (de) |
| EP (1) | EP0236385B1 (de) |
| JP (2) | JP2643934B2 (de) |
| KR (1) | KR920008738B1 (de) |
| CN (1) | CN1030718C (de) |
| AT (1) | ATE69466T1 (de) |
| AU (1) | AU598756B2 (de) |
| CA (1) | CA1340329C (de) |
| DE (1) | DE3682505D1 (de) |
| DK (2) | DK402785D0 (de) |
| FI (1) | FI100252B (de) |
| HU (1) | HU215937B (de) |
| IE (1) | IE59078B1 (de) |
| IL (1) | IL79926A (de) |
| NO (1) | NO301132B1 (de) |
| SU (1) | SU1779263A3 (de) |
| WO (1) | WO1987001387A1 (de) |
| ZA (1) | ZA871267B (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0213628A3 (de) * | 1985-09-03 | 1988-09-21 | Yeda Research And Development Company, Ltd. | Expression von Superoxiddismutase in eukaryotischen Zellen |
| US6610520B1 (en) * | 1985-11-22 | 2003-08-26 | Bio-Technology General Corp. | Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
| JPS63132820A (ja) * | 1986-11-22 | 1988-06-04 | Minoru Nakano | 口腔用組成物 |
| EP0676472A1 (de) * | 1987-03-14 | 1995-10-11 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Humane Mangan-Superoxiddismutase (hMn-SOD) |
| US5260204A (en) * | 1987-03-14 | 1993-11-09 | Boehringer Ingelheim International Gmbh | Human manganese superoxide dismutase (hMn-SOD) |
| DE3854678T2 (de) * | 1987-03-27 | 1996-06-13 | Bio Technology General Corp | Menschliches Mangansuperoxiddismutase und Behandlungsverfahren. |
| DK310788A (da) * | 1987-06-09 | 1988-12-10 | Int Cardiovascular Med Inc | Praeparat indeholdende superoxid-dismutase, dets fremstilling og anvendelse til behandling af global iskaemi |
| JPH01238537A (ja) * | 1988-03-18 | 1989-09-22 | Toyo Jozo Co Ltd | 肝障害治療剤 |
| JPH01246225A (ja) * | 1988-03-28 | 1989-10-02 | Toyo Jozo Co Ltd | 膵炎治療剤 |
| JPH0262829A (ja) * | 1988-05-18 | 1990-03-02 | Nippon Kayaku Co Ltd | 虚血に基づく傷害の予防及び治療剤 |
| DK455789D0 (da) * | 1989-09-15 | 1989-09-15 | Symbicom Ab | Polypeptid |
| DE4038563A1 (de) * | 1990-12-04 | 1992-06-11 | Gruenenthal Gmbh | Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma |
| DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
| EP0627486A1 (de) * | 1993-06-04 | 1994-12-07 | N.V. Innogenetics S.A. | Extra zellulare Superoxyd-Dismutase, Verfahren zur deren Herstellung und diese enthaltende Zusammensetzungen |
| DK75393D0 (da) * | 1993-06-24 | 1993-06-24 | Symbicom Ab | Production of protein |
| US5747026A (en) * | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
| US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
| US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| DE4336641C2 (de) * | 1993-10-22 | 1995-09-07 | Deutsches Rheuma Forschungszen | Verwendung von Superoxid-Dismutase (SOD) zur Behandlung retroviraler Erkrankungen |
| AU3758695A (en) * | 1994-09-20 | 1996-04-09 | Duke University | Oxidoreductase activity of manganic porphyrins |
| ATE205723T1 (de) * | 1994-11-04 | 2001-10-15 | Polymun Scient Immunbio Forsch | Applikation von sod in liposomen |
| MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
| WO1999006059A2 (en) * | 1997-07-30 | 1999-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
| US6171856B1 (en) | 1997-07-30 | 2001-01-09 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
| JP2001521939A (ja) | 1997-11-03 | 2001-11-13 | デューク・ユニバーシティー | 置換されたポルフィリン類 |
| JP4648542B2 (ja) | 1998-04-24 | 2011-03-09 | デューク ユニバーシティ | 置換ポルフィリン |
| WO2000043395A1 (en) | 1999-01-25 | 2000-07-27 | National Jewish Medical And Research Center | Substituted porphyrins |
| ES2330728T3 (es) * | 2001-01-19 | 2009-12-15 | National Jewish Health | Medicamento para proteccion en radioterapia. |
| FI20010898A0 (fi) * | 2001-04-30 | 2001-04-30 | Ylae Herttuala Seppo | Ekstrasellulaarinen superoksididismutaasi (EC-SOD) geeniterapia restenoosoin ehkäisemiseksi |
| AU2002312194B8 (en) * | 2001-06-01 | 2008-05-15 | Aeolus Sciences, Inc. | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| EP1499344A1 (de) * | 2002-04-30 | 2005-01-26 | FIT Biotech Oyj Plc | Medizinische vorrichtung |
| JP2006501163A (ja) * | 2002-06-07 | 2006-01-12 | デューク・ユニバーシティー | 置換ポルフィリン |
| EP1692187B1 (de) * | 2003-10-31 | 2012-06-27 | Tae-Yoon Kim | EC SOD und zelltransduzierende EC SOD und Verwendung davon |
| CN100345973C (zh) * | 2004-11-18 | 2007-10-31 | 中国农业大学 | 超氧化物歧化酶基因的表达方法及其专用载体 |
| RU2506083C2 (ru) | 2008-05-23 | 2014-02-10 | Нэшнл Джуиш Хелт | Способ лечения поражений, ассоциированных с воздействием алкилирующих веществ |
| US20100098768A1 (en) * | 2008-10-16 | 2010-04-22 | Clarkson University | Method of neuroprotection from oxidant injury using metal oxide nanoparticles |
| CN102660580A (zh) * | 2012-05-18 | 2012-09-12 | 深圳市北科生物科技有限公司 | Sod基因修饰间充质干细胞的构建方法及其应用 |
| MX363474B (es) * | 2013-03-15 | 2019-03-25 | Baxter Int | Inmovilizacion de un agente activo en un sustrato. |
| EP3003413B1 (de) | 2013-06-07 | 2017-12-13 | Baxter International Inc. | Immobilisierung eines wirkstoffs auf einem substrat mittels verbindungen mit trihydroxyphenylgruppen |
| CN104342409B (zh) * | 2014-06-17 | 2018-05-25 | 吉林金梓源生物科技股份有限公司 | 重组人参超氧化物歧化酶的制备方法 |
| CN104342408B (zh) * | 2014-06-18 | 2018-05-25 | 吉林金梓源生物科技股份有限公司 | 重组蛹虫草超氧化物歧化酶的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK145950C (da) * | 1979-05-17 | 1983-09-26 | Forenede Bryggerier As | Fremgangsmaade til isolering af cu,zn-superoxid-dismutase fra vandige oploesninger indeholdende dette enzym sammen med ledsagende proteiner |
| US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| JPS56102787A (en) * | 1980-01-18 | 1981-08-17 | Mamoru Sugiura | Preparation of human placenta superoxide dismutase |
| JPS5729285A (en) * | 1980-07-30 | 1982-02-17 | Takeda Chem Ind Ltd | Superoxide dismutase and its preparation |
| JPS57155991A (en) * | 1981-03-23 | 1982-09-27 | Green Cross Corp:The | Preparation of superoxide dismutase derived from human placenta |
| EP0091539B2 (de) * | 1982-03-31 | 1996-11-27 | Ajinomoto Co., Inc. | Das Polypeptid Interleukin-2 kodierendes Gen, rekombinante, dieses Gen enthaltende DNA, diese rekombinante DNA aufweisende Zelllinien und Verfahren zur Herstellung von Interleukin-2 unter Verwendung der genannten Zellen |
| IT1150598B (it) * | 1982-12-14 | 1986-12-17 | Ines Bianchi | Procedimento per la purificazione della superossidodismutasi mediante cromatografia di affinita' |
| EP0138111B1 (de) * | 1983-10-03 | 1991-11-21 | Chiron Corporation | Klonieren von Superoxid-Dismutase und Expression in Mikroorganismen |
| JPS61111690A (ja) * | 1984-11-06 | 1986-05-29 | Ube Ind Ltd | 組換えｄｎａおよびその用途 |
| JPS61139390A (ja) * | 1984-12-13 | 1986-06-26 | Nippon Kayaku Co Ltd | ひとｓｏｄをコ−ドする新規ｄｎａおよびそれを有する微生物 |
-
1985
- 1985-09-03 DK DK402785A patent/DK402785D0/da unknown
-
1986
- 1986-09-02 HU HU864441A patent/HU215937B/hu not_active IP Right Cessation
- 1986-09-02 KR KR1019870700381A patent/KR920008738B1/ko not_active IP Right Cessation
- 1986-09-02 EP EP86905243A patent/EP0236385B1/de not_active Expired - Lifetime
- 1986-09-02 WO PCT/DK1986/000098 patent/WO1987001387A1/en active IP Right Grant
- 1986-09-02 DE DE8686905243T patent/DE3682505D1/de not_active Expired - Fee Related
- 1986-09-02 IL IL7992686A patent/IL79926A/en not_active IP Right Cessation
- 1986-09-02 CN CN86106774A patent/CN1030718C/zh not_active Expired - Fee Related
- 1986-09-02 JP JP61505070A patent/JP2643934B2/ja not_active Expired - Lifetime
- 1986-09-02 AT AT86905243T patent/ATE69466T1/de not_active IP Right Cessation
- 1986-09-02 IE IE234286A patent/IE59078B1/en not_active IP Right Cessation
- 1986-09-02 AU AU63708/86A patent/AU598756B2/en not_active Ceased
- 1986-09-03 CA CA000517419A patent/CA1340329C/en not_active Expired - Fee Related
-
1987
- 1987-02-20 ZA ZA871267A patent/ZA871267B/xx unknown
- 1987-04-28 FI FI871853A patent/FI100252B/fi not_active IP Right Cessation
- 1987-04-30 SU SU874202612A patent/SU1779263A3/ru active
- 1987-04-30 NO NO871816A patent/NO301132B1/no unknown
- 1987-05-01 DK DK224587A patent/DK224587A/da not_active Application Discontinuation
-
1990
- 1990-08-27 US US07/576,114 patent/US5130245A/en not_active Expired - Lifetime
-
1996
- 1996-04-23 JP JP8101552A patent/JP2688190B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI100252B (fi) | 1997-10-31 |
| JP2688190B2 (ja) | 1997-12-08 |
| IL79926A0 (en) | 1986-12-31 |
| WO1987001387A1 (en) | 1987-03-12 |
| FI871853A0 (fi) | 1987-04-28 |
| DK224587D0 (da) | 1987-05-01 |
| DE3682505D1 (de) | 1991-12-19 |
| HUT46059A (en) | 1988-09-28 |
| AU6370886A (en) | 1987-03-24 |
| KR920008738B1 (ko) | 1992-10-08 |
| CN86106774A (zh) | 1987-07-15 |
| IE862342L (en) | 1987-03-03 |
| JPS63501473A (ja) | 1988-06-09 |
| CA1340329C (en) | 1999-01-26 |
| IL79926A (en) | 1994-10-07 |
| AU598756B2 (en) | 1990-07-05 |
| EP0236385B1 (de) | 1991-11-13 |
| ZA871267B (en) | 1987-10-28 |
| FI871853A (fi) | 1987-04-28 |
| CN1030718C (zh) | 1996-01-17 |
| NO871816L (no) | 1987-07-02 |
| JP2643934B2 (ja) | 1997-08-25 |
| KR880700066A (ko) | 1988-02-15 |
| SU1779263A3 (ru) | 1992-11-30 |
| IE59078B1 (en) | 1994-01-12 |
| HU215937B (hu) | 1999-03-29 |
| JPH08317793A (ja) | 1996-12-03 |
| DK402785D0 (da) | 1985-09-03 |
| DK224587A (da) | 1987-05-01 |
| NO301132B1 (no) | 1997-09-15 |
| NO871816D0 (no) | 1987-04-30 |
| EP0236385A1 (de) | 1987-09-16 |
| US5130245A (en) | 1992-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE69466T1 (de) | Superoxyddismutase. | |
| KR880701736A (ko) | Il-6의 제조방법 및 용도 | |
| EP0244234A3 (en) | Transformation of trichoderma | |
| AU6329694A (en) | Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase | |
| ES8600783A1 (es) | Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano. | |
| DE59407809D1 (de) | Tumorizide t-lymphozyten | |
| EP0222591A3 (en) | Method and nucleic acid for the preparation of lecithin: cholesterol acyltransferase | |
| DE3852870T2 (de) | Saurer Fibroblast-Wachstumsfaktor-Mutant. | |
| EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production | |
| ES8801949A1 (es) | Un procedimiento para la preparacion de un vector de expresion que comprende un gen que codifica una proteina envolvente de un virus de sida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |